PUBLISHER: The Business Research Company | PRODUCT CODE: 2133835
PUBLISHER: The Business Research Company | PRODUCT CODE: 2133835
Precision fermentation-derived biomaterials refer to materials manufactured through controlled fermentation using engineered microorganisms to produce targeted biological compounds, including proteins, enzymes, polymers, and other functional biomolecules. This approach combines synthetic biology, metabolic engineering, and bioprocessing technologies to facilitate the efficient, scalable, and sustainable manufacturing of bio-based materials.
The primary product types of precision fermentation-derived biomaterials include proteins, enzymes, lipids, polysaccharides, peptides and growth factors, and other biomolecules. Proteins refer to biologically produced functional macromolecules manufactured through engineered microbial fermentation processes for use across a range of industries. The different microbial hosts include yeast, bacteria, fungi, and algae. The distribution channels include direct sales, distributors, and contract manufacturing, while the major applications include medical and healthcare, food and beverage, cosmetics and personal care, industrial and specialty materials, and agriculture and animal feed.
Tariffs are influencing the precision fermentation-derived biomaterials market by increasing the costs of imported bioprocessing equipment, fermentation systems, specialty enzymes, and raw materials required for large-scale biomaterial production. This is slowing production expansion and commercialization efforts, particularly in regions dependent on imported biotechnology products and equipment such as Asia-Pacific and Europe. Equipment-intensive segments such as proteins, enzymes, and industrial bioprocessing systems are most affected because of their dependence on international supply chains. However, tariffs are also encouraging local manufacturing, diversification of regional suppliers, and increased investment in domestic biotechnology and bio-manufacturing ecosystems, creating greater long-term resilience in the market.
The precision fermentation-derived biomaterials market research report is one of a series of new reports from The Business Research Company that provides precision fermentation-derived biomaterials market statistics, including precision fermentation-derived biomaterials industry global market size, regional shares, competitors with a precision fermentation-derived biomaterials market share, detailed precision fermentation-derived biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the precision fermentation-derived biomaterials industry. This precision fermentation-derived biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The precision fermentation-derived biomaterials market size has grown exponentially in recent years. It will grow from $0.6 billion in 2025 to $0.84 billion in 2026 at a compound annual growth rate (CAGR) of 40.8%. The growth in the historic period can be attributed to growing demand for sustainable biomaterials, advancements in synthetic biology research, increasing investments in industrial biotechnology, rising adoption of bio-based alternatives across food and healthcare applications, and expansion of fermentation infrastructure capabilities.
The precision fermentation-derived biomaterials market size is expected to see exponential growth in the next few years. It will grow to $3.26 billion in 2030 at a compound annual growth rate (CAGR) of 40.3%. The growth in the forecast period can be attributed to increasing commercialization of precision fermentation products, rising demand for alternative proteins and enzymes, growing integration of automated bioprocessing systems, expansion of biomanufacturing partnerships and collaborations, and increasing focus on low-carbon material production. Major trends in the forecast period include scalable production of bio-based materials, increasing adoption of microbial fermentation platforms, development of animal-free biomaterials, expansion of high-purity functional biomolecule manufacturing, and growing commercialization of next-generation bioprocessing technologies.
The increasing global preference for animal-free products is expected to propel the growth of the precision fermentation-derived biomaterials market going forward. Animal-free products refer to plant-based, fermented, or cell-free alternatives that are developed without using animal-derived inputs. The growing preference for these products is driven by increasing consumer awareness of health, sustainability, and ethical considerations, along with the improved availability of high-quality alternatives. Precision fermentation-derived biomaterials play an important role in this transition by providing scalable and sustainable ingredients that replicate the functionality of animal-derived components, supporting the production of plant-based dairy, meat, and related products. For instance, in January 2025, according to Veganuary, a UK-based global organization, approximately 25.8 million people worldwide participated in the Veganuary campaign, demonstrating the increasing adoption of vegan lifestyles. Therefore, the increasing global preference for animal-free products is driving the growth of the precision fermentation-derived biomaterials market.
Leading companies operating in the precision fermentation-derived biomaterials market are focusing on developing innovative solutions, such as precision-fermented functional dairy proteins, to meet the rising demand for animal-free, sustainable, and high-performance biomaterials. Precision fermentation utilizes engineered microorganisms to produce specific proteins and biomolecules without relying on animal sources, offering advantages such as reduced environmental impact, consistent quality, and scalable production compared to conventional methods. For example, in March 2025, Vivici, a Netherlands-based precision fermentation ingredients company, launched Vivitein BLG, an animal-free beta-lactoglobulin (BLG) dairy protein, in the U.S. market. Produced through microbial fermentation, the ingredient delivers functional and nutritional properties comparable to traditional whey proteins and is suited for applications such as protein beverages, powders, and vegan-friendly nutrition products. Additionally, the product offers lower water usage and a reduced carbon footprint compared to conventional dairy protein production, highlighting the role of precision fermentation in advancing sustainable and high-performance biomaterials.
In May 2025, Amyris, Inc., a US-based biotechnology company, acquired complete ownership of the RealSweet precision fermentation plant for an undisclosed amount. Through this acquisition, Amyris seeks to enhance its production capabilities for fermented ingredients utilizing precision fermentation technology. The RealSweet precision fermentation plant is a Brazil-based facility that manufactures specialty biomaterials through industrial-scale precision fermentation, facilitating the scalable and sustainable production of high-quality ingredients.
Major companies operating in the precision fermentation-derived biomaterials market are Evonik Industries AG, Novozymes A/S, Perfect Day Inc., Impossible Foods Inc., Standing Ovation SAS, The EVERY Company Inc., Formo Bio GmbH, Melt & Marble AB, TurtleTree Labs Pte. Ltd., Imagindairy Ltd., Eden Brew Pty Ltd., Onego Bio Ltd., Planet A Foods GmbH, Remilk Ltd., Verley GmbH, Vivici B.V., Change Foods Inc., De Novo Foodlabs Inc., Protera Bio SAS, Helaina Inc., Zero Cow Factory Pvt. Ltd., MeliBio Inc., Motif FoodWorks Inc., Shiru Inc., C16 Biosciences Inc., New Culture Inc., Better Dairy Ltd.
North America was the largest region in the precision fermentation-derived biomaterials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision fermentation-derived biomaterials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the precision fermentation-derived biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The precision fermentation-derived biomaterials market consists of revenues earned by entities by providing services such as strain engineering services, fermentation process development services, bioprocess optimization services, downstream processing services, and contract manufacturing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The precision fermentation-derived biomaterials market also includes sales of bioreactors, fermentation tanks, microbial strains, growth media, enzymes, proteins, bio-based polymers, purification systems, filtration equipment, and process control systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Precision Fermentation-Derived Biomaterials Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses precision fermentation-derived biomaterials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for precision fermentation-derived biomaterials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The precision fermentation-derived biomaterials market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.